WellDoc/AADE Partner to Promote Digital Diabetes Self-Management Platform

The American Association of Diabetes Educators (AADE), announced today they will partner with digital healthcare company WellDoc to incorporate the “AADE Diabetes Education Curriculum: A Guide to Successful Self-Management” in the BlueStar® digital therapeutic platform. BlueStar® is an FDA-cleared digital therapeutic used to help adults living with type 2 diabetes self-manage their condition.

This partnership marks the first time AADE, a professional membership organization comprised of healthcare professionals from multiple disciplines dedicated to improving diabetes care through innovative education, management and support, has partnered with an organization to provide its curriculum in a consumer-friendly digital format. The curriculum, built around the AADE7 Self-Care Behaviors™, focuses on the seven primary areas of self-management: Healthy Eating, Being Active, Monitoring, Taking Medication, Problem Solving, Reducing Risks and Healthy Coping.

“The dual engagement of the person with diabetes and his or her clinical care team is the core of what makes BlueStar a successful tool in helping improve outcomes in type 2 diabetes by reducing A1C for our users,” said WellDoc President and CEO Kevin McRaith. “Working with AADE and its membership is both a natural and positive fit for WellDoc. The AADE curriculum is best-in-class and offering it in a consumer-friendly digital format will only further enhance the value of BlueStar.”

As part of this partnership, AADE and WellDoc will explore how to collectively engage AADE’s members. The organizations will also look to jointly develop new strategies that bring innovative tools to diabetes education and intervention through digital health channels. BlueStar currently provides a platform that allows healthcare professionals (including diabetes educators and care coordinators) to support people with type 2 diabetes in between office visits.

“Digital health is a strong complement to in-person care and education provided by diabetes educators. It is beneficial for AADE to leverage meaningful partnerships with digital health leaders, such as WellDoc, to make every tool available to people living with type 2 diabetes,” said AADE CEO Charles MacFarlane, FACHE, CAE. “Integrating our curriculum into the BlueStar platform is an important strategic decision for AADE and will benefit our members and people with type 2 diabetes in this evolving healthcare environment. We look forward to continuing to build on this relationship.”

You may also like

  • Liraglutide Increases Insulin Sensitivity Independent of Weight Loss, Study Shows

    Liraglutide, the glucagon-like peptide-1 receptor (GLP-1R) agonist used to treat type 2 diabetes and obesity, can lead to rapid improvement in insulin sensitivity, according to a study recently published in Diabetes. “We know that GLP-1R agonists promote weight loss, but we were surprised to find that the GLP-1R agonist liraglutide also has rapid effects on…

  • COVID-19 Vaccines and Hyperglycemia in Patients with Type 1 Diabetes

    While proven to be safe, the COVID-19 vaccines could cause some people with type 1 diabetes to see their blood sugar to temporarily spike. The key for both patient and provider is to remain vigilant with glucose testing and insulin dosing post-jab to maintain glycemic control.  In the summer of 2021, a 24-year-old woman presented…